The US economy continues with its V-shaped recovery as the Delta variant is not a problem for North America as of today.
On Thursday, data showed that the number of US citizens filing first-time applications for unemployment benefits dropped last week to a 16-month low. Meanwhile, worker shortages and bottlenecks in the supply chain prevented businesses from boosting production to deal with the increasing demand for goods and services.
Fed Chairman Jerome Powell told Congress he expected the shortages and inflation to be a temporary issue. However, many economists and investors are concerned that more sustained inflation could force the Fed to tighten the monetary policy sooner than expected.
6 Meridian CIO Andrew Mies told Reuters:
“People are very nervous and concerned about inflation, tax rates and the (2022 midterm) election. Those three things are very much on people’s minds.”
Nevertheless, the bigger picture is great as businesses expand their operations. The OTCQX Composite Index continues to fluctuate near its ATH, with many small-cap firms showing great potential.
OTC MARKETS THE PLACE TO BE
There are many good OTC stocks that can boost your portfolio’s value in the long term. For investors, we preach the key to trading hot OTC stocks is finding momentum BEFORE it happens and then be patient.
We always alert our subscribers first before we publish for our regular readers. This is the value of having a subscription to Insider Financial, which you can sign up for here. We alert our subscribers with our best ideas before our regular readers.
If you watch the Insider Financial YouTube channel, you can get a sense of the ideal time to book profits. We warned our subscribers not to get greedy or get caught up in the diamond hands/paper hands BS.
We also recommend you own a portfolio of OTC stocks. For some, that can be as many as 10 to 20 or more OTC stocks. This provides diversification and allows one to manage the market’s moods much easier. It also helps to own shares in the following 4 trending OTC stocks gaining momentum.
Today, we’ll look at 4 trending OTC stocks that will greatly reward patient investors. They are AppYea, Inc (OTCPK: APYP), Fernhill Corp (OTCPK: FERN), Video River Networks, Inc (OTCPK: NIHK), and Net Savings Link, Inc (OTCMKTS: NSAV).
OTC Stocks to Watch #1 APYP
AppYea, Inc has been correcting during the last five days, but the OTC stock is on track to become a major winner in the coming months. The share price fell 44% to $0.0041 and is likely to find strong support at $0.0037. The price hit $0.0077 on July 9, getting close to February’s one cent, which remains the highest level year-to-date (YTD) and since 2015. Still, the long-term bull run is only making its first steps.
There are several things happening with APYP that we think are significant and can propel the OTC stock to new highs.
Previously, the company used to engage in mobile applications for iOS, Google Play, and Amazon platforms and marketing certain products and services to healthcare providers. Through its wholly-owned subsidiary, The Diagnostic Centers, Inc., AppYea used to market comprehensive diagnostic testing services to physician offices, clinics, hospitals, long-term care facilities, healthcare groups, and other healthcare providers.
At the beginning of the year, the company welcomed three new subsidiaries, one of which it is about to engulf and transform it completely. The new subsidiaries are:
- 1283455 BC LTD – it is focused on blockchain and cryptocurrencies. While blockchain is a promising industry, there is no information about this company and whether it has operations at all.
- Doorstash Delviery Inc – this company is operating in the cannabis industry, another promising sector with a lot of opportunities for investors.
- SleepX Ltd – this Israeli company is the real thing for APYP. SleepX is launching a new patented product representing an anti-snoring device that can communicate with the smartphone. SleepX has high expectations of its product, which will be delivered to buyers in the first quarter of 2022. When the wristband device detects any irregular breathing patterns or snoring, it vibrates mildly not enough to wake the subject, but just enough to induce them into a lighter sleep phase. After repeated use, the device trains the brain to breathe properly.
At the beginning of July, Boris Molchadsky, a resident of Israel and co-founder of SleepX, acquired in a private transaction 45 million Shares of Series A Preferred Stock of APYP, thus becoming the largest shareholder in the company. The Series A Preferred Shares have the right to vote 1,000 to 1 as common shares and convert into 1,500 to 1 of the common shares of AppYea. As of the result of that transaction, Molchadsky controls about 68.2% of the total voting power of APYP.
Molchadsky has been working in the field of sleep health in collaboration with the world’s leading research institutions, with an emphasis on building a strong patent portfolio, manufacturing infrastructure, and distribution channels. He has 15 years of experience in the capital markets through leading investment firms.
Meanwhile, APYP is moving from South Dakota to Nevada and is updating its website. It will also change its name to better reflect the new products provided by SleepX.
— Penny Stocks Today (@Pennystockznews) July 12, 2021
Nevertheless, APYP hasn’t released any official news about the reverse merger, which upset many shareholders. It should do these days, which will likely support the share price.
As for SleepX, its wristband product called DreamIT might be a great innovation that solves sleep problems such as apnea.
— SleepX Ltd. (@SleepXclear) May 31, 2021
They say simple does it. Could @SleepXclear really help managing sleep apnea? Currently no product on the market seems to work well. $APYP sure has a tremendous growth potential with a patent-loaded solution addressing this serious health problem.https://t.co/VKsNxJJgG4
— Milan Dubravka (@milanezule) July 12, 2021
If SleepX manages to generate considerable revenue after launching the product next year, APYP can turn into something big. We’re quite bullish on this OTC stock.
$APYP from coming Monday will start turning into a REAL COMPANY with @SleepXclear dont forget it will give you an $ENZC type price action with all the incoming updates for a 30 Billion Market space for Anti Snoring Product which will be competing with FITBIT type products. pic.twitter.com/V5BqZe3Li9
— Qasim Khan 🇵🇰🇨🇦 (@QasimTradeX) July 9, 2021
OTC Stocks to Watch #2 FERN
We first mentioned Fernhill Corp in mid-May, pointing to the fact that the company had no website and social media presence but could benefit from the great industries it focused on. There have been more relevant updates since then, which suggest that the company is moving in the right direction and might grow really fast.
FERN has gained over 70% during the last five days, trading at $0.012. It hit two cents in mid-May.
The company is promoting itself as a diversified technology holding company that has interests in businesses in multiple sectors, including mobile applications, blockchain and cryptocurrencies, fintech, Next Generation technologies (like artificial intelligence), alternative energy including solar and battery storage, as well as other technologies that address the world’s leading environmental concerns.
On July 12, FERN announced that it had signed a letter of intent (LOI) to acquire a SaaS-based algorithmic cryptocurrency mining operating system platform aimed at crypto mining pools and individual miners. The platform offers optimized algorithms to improve crypto mining yields and operating efficiencies with a mining rig or mining pool. The acquisition is scheduled to close no later than July 28, 2021.
FERN repeatedly mentions in its updates that it is targeting several acquisitions and eventually aims to reach on Nasdaq. We think there is a lot of potential with this OTC stock. The cryptocurrency market has been in bearish mode in the second quarter, but it will bounce back again, and FERN is poised to be a big winner if it continues to invest in crypto businesses.
OTC Stocks to Watch #3 NIHK
Video River Networks, Inc – a Pink Current $22 million company – has performed quite well during the last five days, gaining over 60% to trade at $0.11. The OTC stock touched the YTD high at $0.17 in mid-March when it reported record profit for the first quarter of the year.
NIHK is a tech-oriented holding firm that operates and manages a portfolio of electric cars, artificial intelligence (AI), machine learning, and robotics assets, businesses, and operations in North America. The company’s current and target portfolio businesses and assets include operations that design, develop, manufacture and sell high-performance fully electric vehicles and design, manufacture, install and sell power controls, battery technology, wireless technology, and residential utility meters and remote, mission-critical devices mostly engineered through AI, machine learning and robotic technologies.
Prior to September 15, 2020, NIHK used to be a specialty real estate firm, focuses on the acquisition, ownership, and management of specialized industrial properties.
NIHK saw its first profitable quarter in its most recent history, when it posted revenue of $665 thousand, up 34% y/y, and quarterly earnings per diluted share of $0.002, up 4,391%.
On July 15, the company announced that it had signed a deal to acquire Drone Guarder Inc. (OTC:DRNG), a security and surveillance company that focuses on commercializing a drone and AI technology-enhanced home security system as a turnkey solution locally and internationally. DRNG will remain an independent company, with Adam Taylor keeping his position as president and CEO. NIHK had also hired a Northrop Grumman aerospace veteran to help DRNG’s drone and AI division. Northrop Grumman is an NYSE-listed company with a market cap of about $60 billion.
— Canadian Jennifer 🇨🇦 (@cdntradegrljenn) July 15, 2021
All in all, NIHK has recently transformed its business and is aiming to continue its expansion, which will reflect in the share price.
OTC Stocks to Watch #4 NSAV
Net Savings Link, Inc. has been in bullish mode this month, after correcting from February’s YTD high of 5 cents. At the time of writing, the share price is fluctuating near $0.024. We presented our bullish scenario for NSAV in March, anticipating the acquisition of the Swiss-based crypto platform VirtuaBroker. At this point, the acquisition is completed and NSAV is preparing to launch the crypto exchange platform.
NSAV is working to become a fully integrated technology company that offers turnkey technological solutions to the cryptocurrency, blockchain, and digital asset industries. Over time, the company intends to provide a wide range of services related to software solutions, e-commerce, financial services, and information technology. We like that NSAV has long-term goals, and we think this might be one of the OTC stocks to hold in the long term.
On July 12, NSAV announced that it would launch its cryptocurrency exchange on August 9. It will own 100% of the exchange, which will carry the NSAV brand name. The company added a countdown timer to its website, https://nsavholdinginc.com/.
The exchange is led by NSAV Director, Yuen Wong, who is also the CEO of LABS Group Limited – the world’s first end-to-end blockchain-powered real estate investment ecosystem. He is also a managing partner at Bitmart, a crypto exchange with 2+ million users worldwide and ranked on CoinMarketCap..
Meanwhile, VirtuaBroker, continues to run as a crypto investment platform powered by AI and offering a full range of trading services, including portfolio management and price search function.
We think NSAV should be part of your portfolio because it has great potential and taps into the crypto space, which will continue to expand in the coming years.
THE FINAL NOTE
Today is a great opportunity to benefit from the stock market’s bullishness and invest in OTC stocks with great potential during a reviving economy. Our job is to identify the best OTC stock alerts with strong fundamentals and let our subscribers pick the ones they like to build a well-diversified portfolio oriented at penny stocks.
All of the 4 OTC stocks discussed today are on the rise and are good stocks to hold. Nevertheless, our best advice is to be patient and enter the market during corrections. Buying dips and selling rips as swing trades remains the best strategy in the penny stock market. Still, whenever an OTC stock is in the middle of a bull run, we recommend our subscribers to book profits.
It’s very important to eye OTC stocks that have room for growth and have yet to make their explosive move. There are plenty of opportunities, and we take our time to monitor hundreds of penny stocks to buy each week, trying to find the best alerts for our subscribers.
Remember, all you need is one or two OTC stocks to succeed in order to crush the market averages.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.